The Diagnostic Value of Superb Microvascular Imaging in Prediction of Uterine Artery Embolization Treatment Response in Uterine Leiomyomas

dc.authoridŞirolu, Sabri/0000-0002-8443-0838;
dc.authorwosidŞirolu, Sabri/AAQ-3208-2020
dc.authorwosidyılmaz, fatma/ABC-8846-2021
dc.contributor.authorSamanci, Cesur
dc.contributor.authorOzkose, Burak
dc.contributor.authorUstabasioglu, Fethi Emre
dc.contributor.authorErol, Burak Caglar
dc.contributor.authorSirolu, Sabri
dc.contributor.authorYilmaz, Fatma
dc.contributor.authorOzkose, Zeynep Gedik
dc.date.accessioned2024-06-12T11:12:42Z
dc.date.available2024-06-12T11:12:42Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjectives We aimed to determine if superb microvascular imaging (SMI) can predict response to uterine artery embolization (UAE) as compared with power Doppler ultrasound. Methods The blood flow and the volume of the dominant leiomyoma was evaluated by power Doppler ultrasonography (PDUS) and SMI 1 day before and 3 months after the UAE procedure. SMI and PDUS blood flow were classified to 4 grades of vascularity. The change in fibroid volume in Grades 0-2 (hypovascular group) was compared to the hypervascular Grade 3 group. Results Twenty-eight women (mean age, 40.9 years; range, 33-53 years) were examined with PDUS and SMI before and 3 months after UAE. The volume reduction was statistically significantly higher hypervascular group (P < .05). When we accept 30% or more volume reduction as a good response to UAE, the positive predictive value, negative predictive value, sensitivity, specificity, and accuracy of SMI were 100, 64, 73.6, 100, and 82.1%, respectively. There was excellent agreement between the two blinded observers in SMI measurements. Conclusions SMI, with its high reproducibility, provides further microvessel information than PDUS in uterine fibroids. It may be a useful tool in prediction of response to UAE treatment and improve counseling and patient selection for UAE versus medical or surgical treatment options.en_US
dc.identifier.doi10.1002/jum.15647
dc.identifier.endpage2615en_US
dc.identifier.issn0278-4297
dc.identifier.issn1550-9613
dc.identifier.issue12en_US
dc.identifier.pmid33599335en_US
dc.identifier.scopus2-s2.0-85100872421en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2607en_US
dc.identifier.urihttps://doi.org/10.1002/jum.15647
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23276
dc.identifier.volume40en_US
dc.identifier.wosWOS:000619119900001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal Of Ultrasound In Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPower Doppler Ultrasounden_US
dc.subjectSuperb Microvascular Imagingen_US
dc.subjectUterine Artery Embolizationen_US
dc.titleThe Diagnostic Value of Superb Microvascular Imaging in Prediction of Uterine Artery Embolization Treatment Response in Uterine Leiomyomasen_US
dc.typeArticleen_US

Dosyalar